Metraipolis › archive › dc_0505dfcd4f17
Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1): Protocol of an international natural history study — Europe PMC PMID:41379803
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41379803
- DOI
- 10.1371/journal.pone.0331163
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T17:49:22.907Z
- SHA-256 of the archived text
a5a3039bcf475938eccbf003c539c6549f59d4c958a36056984c873186639110- Stable URL of this page
https://metraipolis.com/documento/dc_0505dfcd4f17
How to cite
Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1): Protocol of an international natural history study — Europe PMC PMID:41379803 — Europe PMC (en), https://europepmc.org/article/MED/41379803 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0505dfcd4f17 (Metraipolis archive dc_0505dfcd4f17, sha256 a5a3039bcf475938eccbf003c539c6549f59d4c958a36056984c873186639110)
BibTeX
@misc{dc0505dfcd4f17,
title = {Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1): Protocol of an international natural history study — Europe PMC PMID:41379803},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41379803},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0505dfcd4f17; sha256 a5a3039bcf475938eccbf003c539c6549f59d4c958a36056984c873186639110},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41379803. Agents can read the archived copy with the MCP tool read_document.